Depressive Disorder With Panic Attacks After Replacement of an Intrauterine Device Containing Levonorgestrel: A Case Report

Depressive Disorder With Panic Attacks After Replacement of an Intrauterine Device Containing Levonorgestrel: A Case Report

With this case, we strengthen previous observations regarding mood changes under LNG-IUS. Moreover, we illustrate that psychiatric symptoms may also occur as ADRs during the subsequent insertion. Thus, we emphasize that psychiatric symptoms have to be clearly communicated as ADRs to patients with LNG-IUS within a written informed consent and should be routinely examined by gynecologists.

Read More

Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives

Contraception counseling for women with premenstrual dysphoric disorder (PMDD): current perspectives

Progestin-only methods including the progestin-only pill (POP), levonorgestrel (LNG) IUD, etonorgestrel implant or depot medroxyprogesterone acetate (DMPA) have the potential to negatively affect mood symptoms for women with or without baseline mood disorders, including PMDD. Careful counseling and close follow-up is recommended for patients with PMDD seeking these contraceptive methods.

Read More

Hormonal contraception, depression and Academic Performance among females attending college in the United States

Hormonal contraception, depression and Academic Performance among females attending college in the United States

“HC (Hormonal Contraception) use significantly increased the odds of ever being diagnosed with depression in all age groups. Women and their providers should balance the risks and benefits of initiating HC. Specifically, younger women, and be advised of the risks that HC presents in terms of a potential association with depression. Efforts to develop standardized protocols for discussing the risk-benefits for HC therapy should be pursued.”

Read More

Information sur le dispositif intra-utérin Mirena - Point d'information

Information sur le dispositif intra-utérin Mirena - Point d'information

Tout effet indésirable suspecté d’être lié à l’utilisation du dispositif intra-utérin Mirena peut être signalé, par les patientes ou les professionnels de santé, en tant qu’effet indésirable associé à un médicament sur https://solidarites-sante.gouv.fr/soins-et-maladies/signalement-sante-gouv-fr/ .

Read More